DK1392329T3 - Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom - Google Patents

Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK1392329T3
DK1392329T3 DK02733192T DK02733192T DK1392329T3 DK 1392329 T3 DK1392329 T3 DK 1392329T3 DK 02733192 T DK02733192 T DK 02733192T DK 02733192 T DK02733192 T DK 02733192T DK 1392329 T3 DK1392329 T3 DK 1392329T3
Authority
DK
Denmark
Prior art keywords
composition
sulodexide
inflammatory bowel
bowel disease
treatment
Prior art date
Application number
DK02733192T
Other languages
Danish (da)
English (en)
Inventor
Michael Spero
Morris Laster
Noa Shelach
Original Assignee
Keryx Biopharmceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryx Biopharmceuticals Inc filed Critical Keryx Biopharmceuticals Inc
Application granted granted Critical
Publication of DK1392329T3 publication Critical patent/DK1392329T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DK02733192T 2001-05-17 2002-05-19 Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom DK1392329T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29166701P 2001-05-17 2001-05-17

Publications (1)

Publication Number Publication Date
DK1392329T3 true DK1392329T3 (da) 2006-11-27

Family

ID=23121293

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02733192T DK1392329T3 (da) 2001-05-17 2002-05-19 Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom

Country Status (12)

Country Link
US (1) US20030008844A1 (de)
EP (1) EP1392329B1 (de)
JP (1) JP2004534087A (de)
AT (1) ATE333885T1 (de)
AU (1) AU2002304265B2 (de)
CA (1) CA2447280A1 (de)
DE (1) DE60213404T2 (de)
DK (1) DK1392329T3 (de)
IL (1) IL158903A0 (de)
MX (1) MXPA03010493A (de)
NZ (1) NZ530020A (de)
WO (1) WO2003002129A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
MY162179A (en) * 2004-04-01 2017-05-31 Elan Pharm Inc Steroid sparing agents and methods of using same
JP2006117569A (ja) * 2004-10-20 2006-05-11 Juntendo ステロイド依存性あるいはステロイド抵抗性潰瘍性大腸炎治療薬
FR2884422B1 (fr) * 2005-04-18 2008-04-11 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
EP2361242B1 (de) 2008-10-17 2018-08-01 Oryzon Genomics, S.A. Oxidaseinhibitoren und deren verwendung
US8993808B2 (en) 2009-01-21 2015-03-31 Oryzon Genomics, S.A. Phenylcyclopropylamine derivatives and their medical use
EP2480528B1 (de) 2009-09-25 2018-08-29 Oryzon Genomics, S.A. Lysinspezifische demethylase-1-inhibitoren und ihre verwendung
US8946296B2 (en) 2009-10-09 2015-02-03 Oryzon Genomics S.A. Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
WO2011106573A2 (en) 2010-02-24 2011-09-01 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
US9616058B2 (en) 2010-02-24 2017-04-11 Oryzon Genomics, S.A. Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
EP2547208B1 (de) * 2010-03-17 2016-07-27 Troy Technology II, Inc. Formulierung mit biozidleistung
MX2012012111A (es) 2010-04-19 2013-05-30 Oryzon Genomics Sa Inhibidores de demetilasa-1 especifica de lisina y su uso.
JP6054868B2 (ja) 2010-07-29 2016-12-27 オリゾン・ジェノミックス・ソシエダッド・アノニマＯｒｙｚｏｎ Ｇｅｎｏｍｉｃｓ Ｓ．Ａ． Ｌｓｄ１のアリールシクロプロピルアミンをベースとしたデメチラーゼ阻害剤およびそれらの医学的使用
WO2012013727A1 (en) 2010-07-29 2012-02-02 Oryzon Genomics S.A. Cyclopropylamine derivatives useful as lsd1 inhibitors
WO2012045883A1 (en) 2010-10-08 2012-04-12 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
WO2012072713A2 (en) 2010-11-30 2012-06-07 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
EP2712315B1 (de) 2011-02-08 2021-11-24 Oryzon Genomics, S.A. Lysindemethylase-hemmer für myeloproliferative erkrankungen
EP2741741A2 (de) * 2011-05-19 2014-06-18 Oryzon Genomics, S.A. Lysindemethylaseinhibitoren zur entzündungserkrankungen oder -zustände
DK2543357T3 (en) * 2011-07-07 2018-07-02 Holy Stone Healthcare Co Ltd COMPOSITION FOR USE FOR TREATMENT AND PREVENTION OF INFLAMMATION-RELATED DISORDERS
US9469597B2 (en) 2011-10-20 2016-10-18 Oryzon Genomics S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
CN104203914B (zh) 2011-10-20 2017-07-11 奥瑞泽恩基因组学股份有限公司 作为lsd1抑制剂的(杂)芳基环丙胺化合物
EP2857020A4 (de) * 2012-06-05 2015-10-28 Yutoku Pharmaceutical Ind Co Ltd Mirtazapinhaltiges, transdermal absorbierbares, hautadhäsives präparat
GB201211982D0 (en) * 2012-07-05 2012-08-22 Isis Innovation Biomarker
CN104017102B (zh) * 2014-06-19 2016-02-24 深圳市海普瑞药业股份有限公司 乙醇沉淀法从肝素副产物制备舒洛地特原料的方法
US9668991B1 (en) 2015-12-09 2017-06-06 International Business Machines Corporation SCFA colonic composition
CN108354943A (zh) * 2018-02-13 2018-08-03 南方医科大学南方医院 新生霉素用于制备抑制trpv1表达和转运功能的药物的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2426586A1 (de) * 1973-06-14 1975-01-09 Opocrin Srl Verfahren zur herstellung von glukuronil-glukosamin-glykan-sulfaten mit antilipaemischer wirkung
IT1274351B (it) * 1994-10-06 1997-07-17 Alfa Wassermann Spa Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
GB0003048D0 (en) * 2000-02-11 2000-03-29 Dealler Stephen F The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism

Also Published As

Publication number Publication date
MXPA03010493A (es) 2005-06-06
AU2002304265B2 (en) 2008-04-10
DE60213404T2 (de) 2007-08-30
JP2004534087A (ja) 2004-11-11
WO2003002129A1 (en) 2003-01-09
US20030008844A1 (en) 2003-01-09
IL158903A0 (en) 2004-05-12
EP1392329B1 (de) 2006-07-26
EP1392329A1 (de) 2004-03-03
NZ530020A (en) 2005-08-26
DE60213404D1 (de) 2006-09-07
ATE333885T1 (de) 2006-08-15
WO2003002129B1 (en) 2003-08-14
CA2447280A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
DK1392329T3 (da) Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom
DE69930259D1 (de) Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr
BR0210056A (pt) composições e métodos para tratamento de hiperplasia
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
WO2001042231A3 (en) Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
BR0110420A (pt) Agonistas muscarìnicos
KR970704429A (ko) 심혈관 질환의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of cardiovascular diseases)
BR0109729A (pt) Uso de uma combinação de um agente anti-angiogênico e um agente anti-hipertensivo, kit para uso na produção de um efeito anti-angiogênico e/ou efeito redutor da permeabilidade vascular em um animal de sangue quente, e, método de tratamento de um estado doentio associado com a angiogênese
BR0013897A (pt) Uso de ácido linoleico conjugado (cla) ou de um seu derivado, composição tópica cosmética ou dermatológica, e, método de tratamento e/ou de profilaxia de celulite e de depósitos de gordura
DE60230066D1 (de) Pharmazeutische zusammensetzung zur behandlung von psoriasis und anderen hautkrankheiten
JP2003505422A5 (de)
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
BR9811585A (pt) Agonistas de vasopressinas tricìclicas
EE05423B1 (et) IL-18 inhibiitori kasutamine maksakahjustuse ja muude haiguste raviks v?i ennetamiseks sobiva ravimi valmistamiseks, vektori ja raku kasutamine inhibiitori produtseerimisel ning IL-18 inhibiitorit sisaldav farmatseutiline kompositsioon
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
EP1166778A3 (de) Verwendung von Wachstumshormonsekretionsförderer zur Behandlung des systemischen Lupus erythematosus und Entzündlicher Darmerkrankungen
HUP0400553A2 (hu) Gyógyászati készítmények
WO2002102743A3 (de) Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel
DK1194109T3 (da) Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf
FI974444A (fi) N-hydroksiureayhdisteitä anti-inflammatorisina aineina
CO5261512A1 (es) Metodo y composiciones para el tratamiento de las enfermedades pulmonares
MA27157A1 (fr) Methode de traitement d'affections osseuses.
BR0210063A (pt) Composição estável e uso da mesma
RU2007138266A (ru) Комбинация ингибитора стероидсульфатазы и аскомицина